We investigated whether PD-L1 and PD-L2 are expressed by human primary CNS cells (astrocytes, microglia, oligodendrocytes, neurons, brain endothelial cells (HBECs)) under basal and inflammatory conditions using cytokine treatments (IFN-gamma, TNF, IL-1beta).